|

GenSci048 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Changchun GeneScience Pharmaceutical Co., Ltd.1

Indications

  • Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)1
  • Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)1
  • Systemic Sclerosis Associated Interstitial Lung Disease1
  • Arthritis1

Other1 trial

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.